p190RhoGAP is cell cycle regulated and affects cytokinesis by Su, Ling et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 

 
 The Rockefeller University Press, 0021-9525/2003/11/571/12 $8.00
The Journal of Cell Biology, Volume 163, Number 3, November 10, 2003 571–582
http://www.jcb.org/cgi/doi/10.1083/jcb.200308007
 
JCB
 
Article
 
571
 
p190RhoGAP is cell cycle regulated 
and affects cytokinesis
 
Ling Su, Joyce M. Agati, and Sarah J. Parsons
 
Department of Microbiology and The Cancer Center, University of Virginia Health System, Charlottesville, VA 22908
 
190RhoGAP (p190), a Rho family GTPase-activating
protein, regulates actin stress ﬁber dynamics via hydro-
lysis of Rho-GTP. Recent data suggest that p190 also
regulates cell proliferation. To gain insights into the cellular
process(es) affected by p190, we altered its levels by condi-
tional or transient overexpression. Overexpression of p190
resulted in a multinucleated phenotype that was dependent
on the GTPase-activating protein domain. Confocal immuno-
ﬂuorescence microscopy revealed that both endogenous
and exogenous p190 localized to the newly forming and
contracting cleavage furrow of dividing cells. However,
p
 
overexpression of p190 resulted in abnormal positioning
of the furrow speciﬁcation site and unequal daughter cell
partitioning, as well as faulty furrow contraction and multi-
nucleation. Furthermore, levels of endogenous p190 protein
were transiently decreased in late mitosis via an ubiquitin-
mediated degradation process that required the NH
 
2
 
-terminal
GTP-binding region of p190. These results suggest that a
cell cycle–regulated reduction in endogenous p190 levels
is linked to completion of cytokinesis and generation of
viable cell progeny.
 
Introduction
 
The process of cytokinesis is a coordinated series of events
that occurs in late mitosis. Cytokinesis is initiated by specifi-
cation of the cleavage plane, followed by: furrow assembly
and ingression; midbody formation; and cell separation,
which results in the production of two daughter cells, each
with an equal complement of chromosomes and membrane
(Prokopenko et al., 2000; Glotzer, 2001; Zeitlin and Sullivan,
2001).
Although many works indicate that cleavage plane initiation
site selection and cleavage furrow assembly are mediated by
the mitotic spindle (Rappaport, 1997; Bonaccorsi et al.,
1998), the molecular events that link the mitotic spindle to
the newly forming contractile ring are just beginning to
emerge (Dechant and Glotzer, 2003; Gonzalez, 2003; Somers
and Saint, 2003). Furrow formation involves the assembly
of an actin-myosin network, a process that is regulated by
the small G protein, Rho. One model, derived from the
recent work of multiple investigators, suggests that the initial
positioning of the furrow is specified in part by a Rac/Rho
GTPase-activating protein (GAP; MgcRacGAP in humans,
RacGAP50C in 
 
Drosophila melanogaster
 
, and Cyk-4 in
 
Caenorhabditis elegans
 
), that moves to the spindle midzone
by means of binding to a kinesin-like molecular motor
(CHO1 in humans, Pavarotti in 
 
Drosophila
 
, and Zen-4 in
 
C. elegans
 
). There, the Rho family GAP interacts with a cor-
tical RhoGEF (ECT2 in humans; and Pebble in 
 
Drosophila
 
),
resulting in the local activation of Rho. The timing of this
complex formation is regulated by the destruction of cyclin
B and cyclin B3. Together, these events form a scenario in
which the molecular motor-Rac–RhoGAP-RhoGEF-Rho
complex positions the cleavage specification site by juxtaposing
the spindle midzone to cortical actin. The subsequent stage,
cleavage furrow formation and contraction, involves assembly
of myosin II, actin filaments, septins, and actin-interacting
proteins, such as profilin and cofilin, as well as downstream
targets of RhoA, including ROCK, citron kinase, LIM kinase,
and formin-homology proteins. Thus, Rho can influence cleav-
age furrow ingression, as well as the specification site selection.
That RhoGTP is critical for these events is supported by
the finding that levels of active Rho are increased during
cytokinesis, and these elevated levels are required for com-
pletion of cytokinesis (Bishop and Hall, 2000; Prokopenko
et al., 2000; Glotzer, 2001). To achieve and maintain Rho
in its appropriate state of activation during initiation and
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contraction of cleavage furrow, both positive regulators
(RhoGEFs) and negative regulators (RhoGAPs) of Rho are
needed. A number of positive regulators of Rho, including
ECT2 and VAV3 (Fujikawa et al., 2002), localize to the
cleavage furrow, and cells lacking these RhoGEFs fail to re-
cruit actin and other components into the cleavage furrow
and are unable to undergo furrow ingression (Prokopenko et
al., 1999; Bishop and Hall, 2000; Glotzer, 2001), demon-
strating their importance. Microinjection of either RhoGDI
or 
 
Clostridium botulinum
 
 C3 transferase, both potent Rho
inhibitors, prevents the formation of the cleavage furrow in
 
Xenopus
 
 
 
laevis 
 
embryos (Kishi et al., 1993), HeLa cells
(O’Connell et al., 1999), and T lymphocytes (Moorman
et al., 1996). As discussed above, the Rho family GAP,
mgcRacGAP, is critical for cleavage plane specification, but
whether Rho-specific GAPs play a role in furrow specifica-
tion site selection or contraction, especially in higher eukary-
otes, is unclear.
p190RhoGAP (p190) is a multidomain protein (Settle-
man et al., 1992) that includes an NH
 
2
 
-terminal GTP-bind-
ing domain (GBD), a middle domain (MD) with multiple
protein–protein interaction motifs, and a COOH-terminal
GAP domain. The GAP domain, with in vivo specificity for
Rho GTPase (Ridley et al., 1993), plays a crucial role in reg-
ulating actin cytoskeletal rearrangements in axonal pathfind-
ing and stability (Dupont and Blancq, 1999; Brouns et al.,
2000, 2001; Billuart et al., 2001) and in response to growth
factor stimulation (Chang et al., 1995a), integrin engage-
ment (Nakahara et al., 1998; Arthur and Burridge, 2001),
and v-Src transformation (Fincham et al., 1999). p190 is
postulated to function as a negative regulator of Rho,
enhancing the hydrolysis of active RhoGTP to inactive
RhoGDP, which in turn is presumed to lead to an inactiva-
tion of RhoGTP effectors and ultimately actin stress fiber
disassembly (Ridley et al., 1993; Chang et al., 1995a).
There are two distinct p190 proteins, p190A and p190B,
encoded by different genes on different chromosomes. Germ-
line expression of a NH
 
2
 
-terminally truncated p190A
RhoGAP (targeted disruption) results in premature death af-
ter birth, accompanied by defects in neural tube closure
(Brouns et al., 2000, 2001; Billuart et al., 2001). A homozy-
gous deletion of p190B results in reduced cell size, impaired
insulin signaling, decreased adipogenesis and myogenesis
(Sordella et al., 2002, 2003), and decreased incidence of
mammary ductal morphogenesis (Chakravarty et al., 2003).
Developmentally, p190B appears to function differently
than p190A, although the phenotype of the homozygous
null p190A mouse has not yet been reported. Only p190A
(p190) will be discussed in this paper.
Other cellular processes in which p190A has been impli-
cated include apoptosis and suppression of tumor growth.
p190A’s NH
 
2
 
-terminal GTPase domain and COOH-ter-
minal RhoGAP domain can independently suppress Ras-
induced transformation in NIH3T3 cells (Wang et al., 1997).
The p190A gene has been mapped to human chromosome
19q13.3, a region known to be rearranged in a variety of
solid human tumors, including pancreatic carcinomas and
gliomas (Tikoo et al., 2000), and p190A protein levels are
up-regulated during apoptosis induced by castration of the
prostate in rat models (Morrissey et al., 1999). In a mouse
model, p190A inhibits PDGF-induced gliomas (Wolf et al.,
2003). Due to these diverse effects of p190 on cell growth,
we sought to define its mechanism of action.
 
Results
 
Overexpression of p190 induces formation of 
multinucleated cells
 
As our initial approach to investigate the consequences of
overexpression of p190 on cell proliferation, we chose a tet-on
conditional expression system. Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200308007/DC1, shows
that variable amounts of HA-tagged p190 protein were in-
duced in different clones of MDA-MB-468 breast cancer cells
Figure 1.  p190 overexpression results in the multinucleation in MDA-MB-468 breast cancer cells. (a) Immunofluorescence and phase 
contrast of a p190 overexpressor in the presence of Dox. (Bottom right) Open arrows, vacuoles; and closed arrows, nuclei. (b) Quantitation of 
the percent cells in clone 2413-6 that were multinucleated at indicated times of Dox treatment. 100 cells were counted in every treatment 
group and graphed using Microsoft Excel as the mean   SD (n = 3).T
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in a doxycycline (Dox) concentration– and time-dependent
manner and that the maximum inducible level of p190
achieved was about twofold above the endogenous p190 level.
Fig. 1 a shows that Dox-induced overexpression of p190
resulted in the formation of giant cell bodies with abnormal
vacuoles, and the presence of two or more nuclei per cell.
Quantitative analysis (Fig. 1 b) revealed that p190 overex-
pression significantly increased the formation of multinucle-
ated cells (
 
 
 
20%), compared with the vector control (7%)
and parental MDA-MB-468 cells (5%), and that the num-
ber of nuclei increased with longer times of exposure to Dox
(up to 6 d). Similar results were observed in different clones
of tet-inducible p190 overexpressors. However, the magni-
tude of the effect was dependent on the level of expression of
exogenous p190, as seen in different clones and in different
cells within a clonal population. The multinucleated pheno-
type exhibited by p190 overexpressors suggested that p190
overexpression may block cytokinesis.
To determine which domain of p190 was responsible for
the multinucleated phenotype, we generated GBD- and
GAP-domain deletion constructs (
 
 
 
GBD and 
 
 
 
GAP) of
p190 in the MDA-MB-468 tet-on conditional expression
system (Fig. 2 a). As with the full-length p190, 
 
 
 
GBD and
 
 
 
GAP mutants were expressed only in the presence of Dox
(unpublished data). Fig. 2 (b and c) shows that the 
 
 
 
GAP-
expressing cells failed to induce multinucleation, whereas
the 
 
 
 
GBD expressors developed multinucleated cells in
comparable numbers (
 
 
 
17%) to those of 
 
wt
 
 p190 overex-
pressors (
 
 
 
20%). Similar results were obtained when HA-
tagged 
 
wt
 
, 
 
 
 
GBD, and 
 
 
 
GAP p190 encoding plasmids
were transiently transfected into HeLa cells (Fig. 2, d and
e). Multinucleation was also observed in C3H10T1/2 mu-
rine fibroblasts after transient overexpression of p190, sug-
gesting that this phenomenon is not cell line– or type–
specific and that the GAP domain is required for the
multinucleated phenotype.
 
Localization of p190 to the cleavage furrow
 
Using confocal microscopy, we examined the subcellular lo-
calization of endogenous p190 in MDA-MB-468 cells at
different stages of late mitosis, from anaphase to cytokinesis.
Fig. 3 shows that endogenous p190 colocalized with cortical
actin in the cellular membrane and appeared to concentrate
in the cleavage furrow (as did actin) from the initial point of
Figure 2.  The GAP domain of p190 is required for multinucleation. (a) p190 constructs used in this work. (b) Immunofluorescence and phase 
contrast of  GBD and  GAP mutants overexpressed in 468 cells. Representative tet-on clones of  GBD and  GAP p190 were treated 
with 1  g ml
 1 Dox for 72 h and stained for HA-tagged  GBD and  GAP. (c) Quantitation of the percentage of HA positive cells that were 
multinucleated at day 1, 3, or 6 with 1  g ml
 1 Dox treatment. 100 cells were counted in every treatment group and graphed as the mean   SD 
(n = 3).  GBD, GTP-binding domain deletion mutant;  GAP, GAP domain deletion mutant; VC, vector control; and 468, parental 468 cells.   
(d) Hela cells were transiently transfected with plasmids encoding HA-tagged wtp190,  GBD,  GAP, or GFP control vector. 24 h after transfection, 
cycling cells were examined by immunofluorescence for p190 expression and multinucleation. p190-expressing cells were scored positive 
for multinucleation based on DAPI and phase images. 100–150 cells were counted in every transfection group. (e) The percentage of multi-
nucleation was quantitated using GraphPad Prism (n = 4) and graphed as the mean   SEM. *, P   0.01 relative to wt p190. T
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furrow formation (furrow specification site) to the end of
ring contraction. At the end of telophase, when the two
daughter cells began to separate, p190 stained more dif-
fusely. p190 was not detected in the midbody or in the in-
tercellular bridge, although the latter structure could be seen
clearly in phase contrast images. Endogenous p190 also
colocalized with actin at the specification site of the cleav-
age furrow and in the contracting furrow of HeLa cells
(Fig.  S2, available at http://www.jcb.org/cgi/content/full/
jcb.200308007/DC1). In cycling or serum-deprived 10T1/
2 fibroblasts or 468 cells synchronized in the G1 phase of
the cell cycle, p190 was diffusely scattered throughout the
cytoplasm and did not exhibit predominant cortical actin
colocalization (Chang et al., 1995a; unpublished data).
 
Abnormal cleavage furrow plane specification and 
defective furrow ingression upon overexpression 
of p190
 
Fig. 4 shows that overexpressed p190 also localized to the
cleavage furrow, but surprisingly the positioning of furrow
specification sites in many cells appeared to be aberrant, re-
sulting in unequal cell division (note the cells that resemble
budding yeast). Large, multilobed cells were also seen (Fig.
4). The genesis of these latter cells is consistent with multi-
ple cleavage furrow initiation attempts (some of which ap-
pear to have been mislocalized) by a single cell and failure to
complete contraction. These findings support the hypothesis
that overexpressed p190 affects cleavage furrow plane speci-
fication and subsequent ring ingression.
 
Cell cycle–regulated expression of p190 
in MDA-MB-468 human breast cancer cells
 
The effect of overexpression of p190 on cell growth suggested
that the endogenous p190 protein level might be tightly con-
trolled throughout the normal cell cycle. High experimental
variation in immuno-detectable p190 levels from cycling cells
(unpublished data) further supported this notion. To address
this question, populations of MDA-MB-468 cells, blocked at
G1, S, or M phases of the cell cycle, as well as at different
stages of M phase (see Materials and methods), were examined
by Western immunoblotting for levels of p190 protein. Flow
cytometry verified that the synchronization process was suc-
cessful (Fig. 5 a), and Fig. 5 b demonstrates by DAPI staining
that the chromatin patterns were appropriate for each of the
mitotic stages. Endogenous p190 protein level was found to be
transiently reduced in late mitosis, with the lowest level being
observed at 3 h after release from the nocodazole block (Fig. 5,
c and d). This corresponds to the time when cells were under-
going cytokinesis. Normal p190 protein level was regained in
G1. The decrease in p190 protein was also observed in HeLa
cells, with the nadir occurring within 1 h upon release from
nocodazole (as compared with 3 h in 468 cells; a difference
likely due to more efficient synchronization in HeLa cells;
Fig.  S3, available at http://www.jcb.org/cgi/content/full/jcb.
200308007/DC1). Finally, p190 protein was reduced by
 
 
 
50% in a population of 468 cells blocked by double thymi-
dine treatment and released for 10 h (DAPI staining indicated
that the cells were in mitosis 9–11 h after release; unpublished
data), suggesting that the decrease is not an artifact of nocoda-
Figure 3.  Colocalization of endogenous p190 with actin to the cleavage furrow during cytokinesis. Parental 468 cells were doubly arrested 
with thymidine and nocodazole and released from nocodazole for varying lengths of time up to 3 h. p190 and actin were visualized by 
fluorescence confocal microscopy using anti-p190 rabbit polyclonal antibody p27/Texas red–conjugated goat anti–rabbit IgG and FITC-
phalloidin, respectively. Merged fluorescent and phase images are noted. Open arrows indicate cleavage furrow, and closed arrows indicate 
intercellular bridges.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
p190RhoGAP and cytokinesis |
 
 Su et al. 575
Figure 4.  Abnormal positioning of the cleavage furrow specification site, unequal daughter cell partitioning, and aberrant furrow contraction 
in cells overexpressing p190. Dox-treated p190 overexpressing clone 2413-6 of 468 cells was doubly arrested with thymidine and nocodazole 
and released from the nocodazole block, as in Fig. 3. Cells were processed for immunofluorescent confocal microscopy as in Fig. 3, except that 
mAb HA11 and Texas red–conjugated goat anti–mouse IgG were used to detect HA-p190. Arrows indicate cleavage furrow specification sites.
Figure 5.  Cell cycle–regulated levels of p190 protein in MDA-MB-468 cells. (a) Flow cytometry analysis of 468 cells synchronized at different 
cell cycle stages. C represents cycling cells. G0/G1, S, and G2/M represent the population of cells in the G0/G1, S, and G2/M stages of the cell 
cycle, respectively. (b) Chromatin patterns of 468 cells synchronized at different stages of the cell cycle. C represents cycling cells. G1 represents 
cells in the G1 stage of the cell cycle that were synchronized by a double thymidine block. Cells in mitotic phase, obtained by nocodazole 
treatment (M0) and release from nocodazole for 45 min (M1), 90 min (M2), and 180 min (M3), were fixed and stained with DAPI. Chromatin 
patterns are consistent with cells in prometaphase (M0), metaphase (M1), anaphase (M2) and telophase/cytokinesis (M3). (c) Levels of endogenous 
p190 at different stages of the cell cycle. 100  g of whole cell lysate from each cell cycle stage was immunoblotted with 8C10 (for p190) or the 
anti-Erk2 mAb (for MAPK as a loading control). (d) Quantitative analysis of multiple experiments represented by panel c. Each bar represents the 
relative protein level (densitometry of p190 level divided by loading control) and graphed as the mean   SD (n = 3). Densitometry analysis was 
performed with Adobe Photoshop 4.0. M3 protein level is significantly different than the protein level in cycling cells. *, P   0.05.T
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zole treatment. Together, these results indicate that the level of
endogenous p190 protein is cell cycle regulated and undergoes
a decrease in concordance with the onset of cytokinesis.
To determine whether overexpressed p190 was subjected
to similar degradation, we examined levels of Dox-induced
p190 (HA-tagged p190), as well as total p190 (overex-
pressed plus endogenous p190) in a tet-on inducible clone
of MDA-MB-468 cells during cell cycle progression. Fig. 6 a
depicts both HA-p190 and total p190 (HA-tagged p190
plus endogenous p190) levels throughout the cell cycle. In
contrast to endogenous p190, quantitation of multiple ex-
periments showed no significant reduction of total or HA-
tagged p190 protein levels in late mitosis (Fig. 6 b). Similar
results were obtained for different clones of p190 overex-
pressors when exogenous p190 was induced by Dox (unpub-
lished data). The high levels of p190 in late mitosis corre-
lated with the ability of overexpressed p190 to induce the
multinucleated phenotype.
 
The reduction of p190 in late mitosis is regulated 
by ubiquitin-mediated degradation
 
Ubiquitin-mediated protein degradation via the 26S protea-
some plays a key role in cell cycle progression. To investigate
whether the reduced p190 protein levels observed in late mi-
tosis were mediated by proteasome degradation, we analyzed
the levels of endogenous p190 by Western immunoblotting
in synchronized populations of cells that were treated with
or without the proteasome inhibitor, MG132. Fig. 6 c
shows that MG132 treatment maintained constant levels of
p190 throughout all stages of the cell cycle, whereas p190
levels were decreased without MG132 treatment during
later stages of mitosis. Quantitation of multiple experiments
showed no significant reduction of p190 protein levels at the
mitosis in the presence of MG132 (Fig. 6 d). The effect of
MG132 treatment on endogenous p190 protein mimicked
the result of p190 overexpression in the tet-on system. Al-
though these results suggest that proteasome degradation
may play a role in the regulation of endogenous p190 pro-
tein levels during the cell cycle, they are not necessarily an
indication of direct degradation of p190 by the proteasome.
The results could reflect an indirect effect on the levels of
other cell cycle–regulated proteins (such as cyclins) and an
inability to progress through mitosis. In fact, DAPI staining
showed that MG132 induces mitotic arrest, even upon no-
codazole withdrawal.
To test whether p190 is directly ubiquitinated, in vitro
and in vivo ubiquitination works were performed. Fig. 7 a
shows that in vitro–transcribed and –translated p190 was
Figure 6.  Constitutive overexpression of p190 
or the proteasome inhibitor, MG132, overcomes 
p190 degradation. (a) p190 overexpression prevents 
its degradation at late mitosis. Clone 2413-6 was 
treated with 1  g ml
 1 Dox for 24 h and synchro-
nized as in Fig. 5. 100  g of lysate protein was 
subjected to Western immunoblotting by 12CA5 
or 8C10 to detect HA-tagged p190 or total p190 
levels, respectively. MAPK was blotted as a load-
ing control. (b) Quantitation of panel a. Each bar 
represents the normalized protein level (densitometry 
units of p190 divided by loading control), relative 
to the ratio of cycling cells, which was set at one 
and graphed as the mean   SD (n = 3). (c) Inhibition 
of p190 degradation by the proteasome inhibitor, 
MG132. Cells were synchronized as in Fig. 5 and 
left untreated or treated with 20  M MG132. 100 
 g of lysate protein was blotted for endogenous 
p190 protein levels, using mAb 8C10, or MAPK as 
a loading control. (d) Quantitation of panel c. Each 
bar represents the normalized protein level, relative 
to the ratio of cycling cells, which was arbitrarily 
set at one and graphed as the mean   SD (n = 3). 
Densitometry analysis was performed using Adobe 
Photoshop 4.0. M3 protein level is significantly 
different than the protein level in cycling cells. 
*, P   0.05. T
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ubiquitinated in the presence of exogenous ubiquitin and
mitotic extracts prepared from 468 cells blocked in mitosis
(M0) by nocodazole treatment or released from the nocoda-
zole block for the indicated times. Ubiquitination is evi-
denced by the shift of p190 to higher molecular weight
forms, some of which have just entered the gel. Significantly
more ubiquitination was observed with M0 or M1.5 h re-
lease than with the 2.5- or 3-h release extracts (Fig. 7 b),
thereby showing specificity for the process. The decrease in
ubiquitination in the presence of methylated ubiquitin (M),
which inhibits ubiquitin chain formation, also shows speci-
ficity of the reaction.
In vivo ubiquitination of p190 was analyzed in HeLa
cells as described in Materials and methods. Immunopreci-
pates of p190, prepared from cells at different stages of mi-
tosis plus or minus the specific proteasome inhibitor, lacta-
cystin, contained proteins that were ubiquitinated in M0,
as shown by anti-ubiquitin immunoblotting (Fig. 7 c).
However, we were unable to detect laddering of p190 in
the p190 blot of HeLa cells. Thus, using a different com-
bination of antibodies, we tested whether p190 was di-
rectly ubiquitinated by immunoprecipitating p190 from
468 cells and subsequently immunoblotting the precipi-
tated proteins with p190-specific antibodies (Fig. 7 d). A
smeared banding pattern indicative of p190 ubiquitination
in early mitotic samples, but not in cycling or late mitotic
samples, was observed. As in the HeLa cells, the presence
of lactacystin facilitated the appearance of ubiquitinated
forms of p190. These findings suggest that p190 is directly
ubiquitinated and that ubiquitination may play a role in
the control of p190 protein level in mitosis. Different com-
binations of antibodies were needed (see Materials and
methods and Fig. 7 for antibodies used) to detect p190 in
the two cell lines (those used in HeLa cells functioned
poorly in 468 cells and vice versa). The reason for this is
not clear, but one explanation is that p190 may undergo
differential posttranslational modification that results in
epitope masking and inability to detect laddering in the
p190 blot of HeLa cells.
To determine which domains of p190 are ubiquitinated
during mitosis, cDNA plasmids encoding five distinct
HA-tagged regions of p190 (representing the majority of
the sequence of the protein) were generated and subjected
to in vitro ubiquitination assays (using extracts from 468
cells blocked at mitosis), as described in Fig. 7. The re-
gions analyzed included the NH
 
2
 
-terminal GBD and
COOH-terminal GAP domain, as well as sections 1–3 of
the MD (Haskell et al., 2001). Fig. 8 a shows that the
GBD is the most highly ubiquitinated region in mitosis,
followed by section 1 and the GAP domain. Sections 2
and 3 sustained little to no ubiquitination in this analysis.
This result indicated that the majority of p190 ubiquiti-
nation occurs in the GBD.
To determine the functional significance of ubiquitina-
tion, we asked which regions of p190 were critical for deg-
radation. HA-tagged 
 
wt
 
, 
 
 
 
GBD, and 
 
 
 
GAP p190 encod-
ing plasmids were transiently expressed in HeLa cells, and
the level of p190 was followed in cells arrested in mitosis
and released for the indicated times. Fig. 8 (b and c) shows
that 
 
wt
 
 and 
 
 
 
GAP p190 are degraded in late mitosis,
whereas 
 
 
 
GBD is resistant to degradation within the same
time frame. These results link ubiquitination of the GBD
to degradation and suggest that the GTP binding region
plays a key role in the regulation of p190 protein levels in
late mitosis.
 
Discussion
 
Since its discovery, the molecular mechanism by which
p190 regulates cell growth and death has remained elusive.
Reasons for this are many fold. First, both overexpression
(unpublished data) and underexpression (Fig. S4, avail-
able at http://www.jcb.org/cgi/content/ful/jcb.200308007/
DC1) render cells inviable, thus limiting analysis of molecu-
lar events. Second, overexpressors score negatively for apop-
totic markers (such as TUNEL) when cells are cultured in
the presence of serum for up to 96 h, but 
 
 
 
30% are
TUNEL positive in the absence of serum (as compared with
Figure 7.  In vitro and in vivo ubiquitination of 
p190. (a) In vitro ubiquitination reactions using 
35S-labeled p190 and the mitotic extracts (M0, 
M1.5h, M2.5h, and M3h).  , the absence of exo-
genous ubiquitin in the reaction; M, methylated 
ubiquitin; and U, ubiquitin. The last lane is the in 
vitro 
35S-labeled p190 alone. p190(Ub)n denotes 
ubiquitinated p190. (b) Quantitation of multiple 
reactions are expressed as the mean   SEM (n value 
ranging from three to seven experiments per extract). 
*, P   0.05 for M0 and M1.5h compared to M2.5h, 
M3h, or G1/S. (c) In vivo ubiquitination of p190 in 
HeLa cells. HeLa cells were synchronized at differ-
ent stages of mitosis with or without 10  M of 
lactacystin, as described in Materials and methods. 
p190 was immunoprecipitated from 2 mg of lysate 
protein and blotted with anti-ubiquitin or anti-p190 
antibodies. (d) In vivo ubiquitination of p190 in 
MDA-MB-468 cells. 468 cells were synchronized 
as in panel c, and p190 was immunoprecipitated 
from 2 mg of lysate using 8C10 and anti-p190 mAbs 
and immunoblotted with anti-p190 mAb. T
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5% of nonoverexpressors; unpublished data). This finding
suggests that p190 overexpression predisposes cells to the ap-
optotic consequences of serum withdrawal but doesn’t by it-
self cause apoptotic cell death. Third, p190 protein levels in
breast and prostate cancer cell lines are not inversely corre-
lated with the malignant phenotype, as would be expected of
a classical tumor suppressor (unpublished data), although its
GBD and GAP domain reverse Ras-induced NIH3T3 cell
transformation (Wang et al., 1997). Fourth, our findings
that p190 appears to be required for progression through the
earlier stages of the cell cycle (Chang et al., 1995a; Fig. S4)
and is detrimental in the late stages of the cell cycle when
overexpressed (Fig. 4) suggest that it has both positive and
negative regulatory roles to play in cell cycle progression.
From these analyses, we hypothesize that the level of p190
protein is critical for maintaining cell homeostasis and pro-
gression through the cell cycle, notably in late mitosis where
a transient reduction is associated with successful comple-
tion of the process.
At what point in cytokinesis are levels of p190 most criti-
cal? Although it has been well established that the mitotic
spindle is critical for cleavage furrow initiation, recent data
suggest that two independent pathways, centrosome separa-
tion and central spindle assembly, trigger cleavage furrow
initiation by generating a low microtubule density area near
the site of furrow formation (Dechant and Glotzer, 2003).
These actions appear to be coordinated with Rho, as de-
scribed in the Introduction. Our findings that both endoge-
nous and ectopically expressed p190 localize to cleavage fur-
row specification sites and that overexpression of p190
results in abnormal plane specification (Fig. 4) further sup-
port the critical involvement of Rho in furrow initiation and
formation, and identify another potentially important regu-
lator of Rho (p190) in this process as well. Exactly how p190
interdigitates with the known regulators of cleavage furrow
plane specification is unclear at the present time (Gonzalez,
2003) and awaits identification of p190 binding partners.
The presence of p190 in the cleavage furrow throughout
the contraction process suggests that furrow ingression is
also dependent on a critical level of active Rho. Indeed, Pel-
ham and Chang (2002) recently showed that the contractile
ring is a dynamic structure, in which actin and other compo-
nents continuously assemble and disassemble during furrow
contraction. Because Rho and its regulators are key modula-
tors of actin assembly and disassembly, the localization of
Rho GEFs and GAPs in the furrow along with Rho supports
the idea that these molecules are important to the continual
rearrangements that the contractile ring undergoes during
furrow ingression.
However, little to no endogenous p190 can be detected
in the midbody or intercellular bridge, which forms just
before the completion of cytokinesis (Fig. 3). This struc-
ture is assembled between the newly forming daughter cells
as the actomyosin contractile ring comes into close prox-
imity to the central spindle. The absence of p190 from this
structure could be due to the poor penetrance of antibodies
into these structures, thus preventing a definitive interpre-
tation of the results. Alternatively, if p190 is truly absent
from these structures, such a result would suggest that
p190 is not a critical regulator of Rho during this phase of
cytokinesis, although Rho family members have been
linked to these late stages of the process. Other Rho family
GAPs have also been implicated as critical regulators of
midbody formation, including CYK-4 in 
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 and its
Figure 8.  The NH2-terminal GBD of 
p190 is ubiquitinated and required for 
degradation of p190. (a) Schematic repre-
sentation of the p190 fragments subjected 
to the in vitro ubiquitination reaction in b. 
(b) In vitro ubiquitination of different p190 
fragments. GBD, GTPase-binding domain; 
Sect 1, section 1 of the MD; Sect 2, sec-
tion 2 of MD; Sect 3, section 3 of MD; 
GAP, GTPase-activating protein domain; 
and Luc, luciferase control. Arrows de-
note the translated protein without modi-
fication. (c) Degradation of exogenous 
p190 variants in HeLa cells. HeLa cells 
were transiently transfected with the 
indicated HA-tagged p190 expression 
plasmids. 24 h after transfection, cells 
were allowed to continue cycling (C) or 
treated with 40 ng/ml nocodazole (N) for 
16 h, released from the block for 40 min, 
and lysed in RIPA buffer. 100  g of whole 
cell lysate was immunoblotted with anti-
HA mAb, 12CA5 or anti-MAPK B3B9 
mAb as a loading control. (d) Quantitation 
of levels of p190 in cycling and mitotic 
HeLa cells. The ratio of p190 protein/
MAPK from three to five independent 
experiments was quantified by AlphaEase 
software and graphed as the mean   SEM. 
*, P   0.02 relative to cycling cells 
expressing the same p190 variant. T
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human orthologue, mgcRacGAP (Jantsch-Plunger et al.,
2000; Hirose et al., 2001).
The requirement for the GAP domain of p190 to induce
the multinucleated phenotype (Fig. 2) suggests that a critical
role of p190 in cytokinesis is to regulate Rho activity by
modulating the level of RhoGTP. Endogenous p190 levels
are in fact transiently decreased in late mitosis when cytoki-
nesis takes place (Fig. 5), suggesting that elevated RhoGTP
levels are needed to traverse this stage of mitosis. We specu-
late that constitutive overexpression of p190 results in re-
duced RhoGTP levels, thereby causing abnormal cleavage
furrow formation and perhaps ineffective furrow contrac-
tion. Indeed, Maddox and Burridge (2003) have reported
that RhoGTP levels are elevated during normal mitosis, sup-
porting the notion that high RhoGTP (and low RhoGAP
activity) is associated with completion of mitosis. By using
FRET-based probes, Yoshizaki et al. (2003) found that ele-
vated RhoGTP specifically localizes to the cleavage furrow
in late cytokinesis, whereas RacGTP partitions to the spin-
dle poles, and Cdc42GTP is diffusely distributed through-
out the cells. Thus, high levels of RhoGTP occur in the
same time and place that we observe a reduction in p190
protein levels and, concurrently, a decrease in RhoGAP ac-
tivity. That p190 activity may be specifically affecting
RhoGTP levels in the cleavage furrow and not RacGTP or
Cdc42GTP levels is consistent with RhoGTP being the pre-
ferred substrate (vs. Rac and Cdc42) for p190 in vivo (Rid-
ley et al., 1993).
Our finding that gene silencing of p190A results in re-
duced viability and highly adhesive and thinly spread cells
that fail to accumulate in mitosis upon nocodazole treat-
ment (Fig. S4) suggests that too much RhoGTP can also
be detrimental to cell cycle progression. The absence of a
cytokinetic defect in the p190A-targeted disruption mouse
(Brouns et al., 2000, 2001) or in the p190B knockout
mouse (Sordella et al., 2002) appears to conflict with our
findings. However, potential compensatory mechanisms by
other RhoGAPs during development in knockout animals
make interpretation of the phenotypes (or lack thereof)
more problematic. An additional complication is that there
may be some functional redundancy among Rho family
GAPs with regard to cytokinesis (e.g., mgcRacGAP). Fi-
nally, if p190 needs to be degraded (or expression reduced)
for cytokinesis to occur, a knockout or knockdown might
not exhibit a phenotype. Thus, in light of these consider-
ations and the results of our gene silencing experiments, our
best tool to date in understanding the role of p190 in cyto-
kinesis has been the overexpression strategy.
Our data show that multinucleation is accompanied by
large vacuoles in p190 overexpressors. These abnormal vacu-
oles may be caused by perturbation of vesicle transport or
membrane vesicle fusion systems of the cell. Recent data
suggest that membrane vesicle transport to and fusion at the
site of cleavage is required for proper completion of cytoki-
nesis (Straight and Field, 2000; Finger and White, 2002). A
microtubule structure, known as the furrow microtubule ar-
ray, is required for directing membrane vesicles to the site of
the cleavage furrow (Danilchik et al., 1998; Straight and
Field, 2000). Because it is unclear whether p190 localizes to
the midbody (Fig. 3), where substantial membrane deposi-
tion occurs in late cytokinesis, it is possible that p190 plays a
role in membrane recruitment at earlier stages of cytokinesis.
Because p190 is a multidomain protein, it could induce
multinucleation and vacuole formation by independent
mechanisms that involve distinct domains, in addition to its
GAP domain. Support for this notion comes from several re-
ports. Not only is there evidence showing possible involve-
ment of p190 in the endocytosis of the EGF receptor (Wang
et al., 1996), but its associated protein, p120RasGAP, has
also been shown to regulate vesicular transport to the Golgi
apparatus (Kulkarni et al., 2000). In addition, the GTPase
domain in the NH
 
2
 
 terminus of p190 contains motifs that
are closely related to the small G protein, Ypt2, in yeast
(Foster et al., 1994). Ypt (Rab) family proteins are known to
regulate vesicular transport (Haubruck et al., 1990). Recent
data also suggest that c-Src tyrosine kinase may participate in
the process of cytokinesis. c-Src is associated and colocalized
with the diaphanous-related formins, which are Rho GTP-
ase-binding proteins, in endosomes and in midbodies of
dividing cells (Tominaga et al., 2000). Because p190 is a
substrate of c-Src (Chang et al., 1995a; Roof et al., 1998;
Brouns et al., 2001), it is possible that c-Src plays a role in
p190-induced regulation of cytokinesis. Thus, disturbance
of membrane vesicle transport may also contribute to the
p190-induced block in cytokinesis. Further experiments are
needed to identify the origin of the vacuoles in p190 overex-
pressors and their potential role in cytokinesis.
The ubiquitination works depicted in Fig. 7 suggest that
p190 is a target of ubiquitin-mediated degradation in late
mitosis. In further support of its regulated degradation, pro-
tein sequence analysis indicates that p190 contains seven po-
tential ubiquitination motifs, including five destruction
boxes (D-boxes) and two KEN-boxes. The D-box is a well-
characterized ubiquitination motif found in most mitotic
cyclins (King et al., 1996). The consensus sequence of the
D-box, RXXL, is found at residues 346, 833, 872, 903, and
1216 of p190. KEN-boxes (Pfleger and Kirschner, 2000) are
found in the GAP domain (residues 1366–1369) and the
NH
 
2
 
-terminal portion of the MD (residues 437–439) of
p190. Both motifs are recognized by an ubiquitin E3 ligase,
the anaphase promoting complex (Pfleger and Kirschner,
2000) which is active from metaphase to G1. Several other
candidate E3 ligases, like Skp1–cullin–F-box complex and
Chfr (Peters, 1998; Kang et al., 2002), may mediate the
ubiquitination of p190 during mitosis and need to be inves-
tigated.
An analysis of the time courses of ubiquitination versus
degradation raises the question of why the steady-state level
of p190 decreases only upon exit from M phase, if the high-
est ubiquitination activity is in early mitosis. Fig. 7 b shows
that the highest ubiquitinating activity was found in M0 ex-
tracts and in M1.5 h extracts (released from nocodazole in
the absence of MG132 for 1.5 h). Fig. 6 c shows that degra-
dation was apparent in intact cells 2 h after release and that
the nadir of p190 levels was reached at 3 h after release. We
interpret these results to mean that p190 could be ubiquiti-
nated anytime from the moment of entrance into mitosis
through 1.5 h into the process and degraded within 1.5–3 h
afterwards. Whether this means that selected p190 mole-
cules are ubiquitinated and degraded rapidly at specific timeT
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intervals or whether there is a delay between ubiquitination
and degradation of the entire degradable population is a sub-
ject requiring further investigation.
The structure–function analysis depicted in Fig. 8 shows
that the GTP binding region is important for both ubiq-
uitination and degradation of p190 during mitosis. The
 GBD variant represents a nondegradable form of p190
that induces multinucleation when overexpressed tran-
siently in HeLa cells or in the tet-on inducible system in
468 cells (Fig. 2), linking high levels of nondegradable
p190 to disruptions in cytokinesis. These results suggest
that the GBD may function as an autoregulator of endoge-
nous p190 protein level in late mitosis by controlling ubiq-
uitination-mediated degradation. This conclusion is con-
sistent with a previous report demonstrating that the GBD
controls p190 activity (Tatsis et al., 1998). However, a dis-
cordance in the data is revealed by the analysis of full-
length p190, where degradation of the protein was ob-
served in the transient transfectants (Fig. 8), but not in the
tet-on inducible 468 clones (Fig. 6), yet both overexpres-
sion methods resulted in a multinucleated phenotype
(Figs. 1 and 2). These results could be interpreted in sev-
eral ways. On one hand, the discordance may only reflect
differences in the overexpression systems, where the con-
stantly elevated level of p190 in the presence of Dox may
overwhelm the degradation pathway, resulting in high lev-
els of p190, whereas the short-lived, elevated levels in the
transient expression system are more readily proteolyzed.
With such considerations, the hypothesis that degradation
of endogenous p190 is required for successful completion
of cytokinesis remains valid. On the other hand, it is possi-
ble that resistance to ubiquitination-mediated degradation
is not required for overexpressed p190 to induce mul-
tinucleation and that ubiquitination/degradation of en-
dogenous p190 may regulate another process not criti-
cal to completion of cytokinesis. In any event, the data in
both overexpression systems reveal a critical need for the
RhoGAP domain for the effects of p190 overexpression on
cytokinesis and clearly link p190 to this process. This hy-
pothesis is further supported by the fact that RhoGTP lev-
els are elevated during cytokinesis (Yoshizaki et al., 2003)
when we observe a decrease in p190 protein level.
Together, the results in this paper suggest that p190 can af-
fect cytokinesis through its GAP domain by regulating Rho
activity and that this function is controlled by the GTP bind-
ing region through ubiquitination and degradation of p190.
This regulated degradation may be important for completion
of cytokinesis. From this perspective, p190 may act as a regula-
tor of late mitosis (perhaps even at a secondary or tertiary level)
to ensure that cells progress through cytokinesis normally.
Materials and methods
Tissue culture
MDA-MB-468 human breast cancer cells were cultured in DME (GIBCO
BRL) with 5% FBS and antibiotics. Murine C3H 10T1/2 fibroblasts and
HeLa cells were cultured in DME with 10% serum and antibiotics.
Immunofluorescence
Cells were prepared for immunofluorescence as described in Chang et al.
(1995b), except that 2  g ml
 1 anti-HA mAb, HA11 (BabCO), and 1  g
ml
 1 Texas red–conjugated goat anti–mouse IgG (Jackson ImmunoRe-
search Laboratories, Inc.) were used for staining HA-p190. Endogenous
p190 was stained with anti-p190 mAb, 8C10, or polyclonal rabbit anti-
body p27 (derived and characterized in our laboratory; Chang et al.,
1995a, b) as the primary antibodies. For actin localization, cells were incu-
bated with 5 U ml
 1 FITC-labeled phalloidin (Molecular Probes Inc.) in
PBS for 1 h nuclear DNA was stained with 2  g ml
 1 DAPI (Sigma-Aldrich)
in PBS for 3 min. Coverslips were mounted on microscope slides and cells
were viewed on a confocal microscope (model Pascal; Carl Zeiss Micro-
Imaging, Inc.).
HeLa cells were transfected with p190 variants using Polyfect (QIA-
GEN) according to the manufacturer’s instructions. Cells were fixed and
stained as above 24 h after transfection using 2.5  g/ml anti-HA FITC
(Roche), and viewed on a fluorescent microscope (model Orthoplan; E.
Leitz, Inc.).
Western blotting
Cells were grown to  90% confluence at 37 C,lysed, and subjected to
Western blotting as described previously (Chang et al., 1995a), using the
following primary antibodies (1  g ml
 1 in blocking buffer): anti-HA mAb,
12CA5 (BabCO) for HA-tagged p190; 8C10 mAb for endogenous p190;
and mAb B3B9 for MAPK (a gift of M. Weber, University of Virginia, Char-
lottesville, VA). Membranes were incubated with HRP-conjugated anti–
mouse IgG secondary antibody (1:5,000; Amersham Biosciences), and vi-
sualized by ECL (ECL
TM; Amersham Biosciences). Results were quantified
by densitometric analysis using Adobe Photoshop 4.0.
Generation of MDA-MB-468 tet-on p190-inducible cell lines
The tet-on expression system obtained from CLONTECH Laboratories, Inc.
was used according to the manufacturer’s directions. The HindIII–EcoRV
fragments from HA-tagged wild-type p190-A (Rc190-wt) (Settleman et
al., 1992) were inserted into the pTRE-2 vector, respectively, to yield
pTRE190A. HA-tagged  GBD (amino acids 379–1514) and  GAP (amino
acids 1–1180) were cloned into the pTRE-2 vector by PCR. The constructs
were verified by DNA sequencing. Clones of 468 cells were stably trans-
fected with pTet-on, selected in 800  g ml
 1 G418, and screened for
 100-fold Dox inducibility and low background after transient transfec-
tion with the pTRE2-Luc plasmid. Double-stable cell lines were generated
by cotransfecting pTet-on stable clone with pTRE-p190 constructs above
together with pBabe (puromycin) at a ratio of 10:1, respectively, and se-
lected with 400  g ml
 1 G418 and 250 ng ml
 1 puromycin in tissue cul-
ture medium.
Cell cycle synchronization and flow cytometry
Cell cycle–synchronized cells were obtained by treatment with 2 mM thy-
midine (Sigma-Aldrich) in tissue culture medium for 12–16 h; cells were
washed and incubated in normal medium for 8–10 h to release them from
the block. Cells treated in this manner were further enriched for G1/S,
S, and M phases by the following treatments: G1/S phase (400  M
L-minosine [Sigma-Aldrich] for 12–16 h); S phase (2 mM thymidine for
12–16 h, washed, and replaced with normal medium for 4 h); and M
phase (40 ng ml
 1 nocodazole [Sigma-Aldrich] for 12–16 h). M phase cells
were washed in PBS and released from the nocodazole block by addition
of fresh medium (45–240 min). MG132 (Sigma-Aldrich) at 20  M was
added during the release from nocodazole for some experiments. Cells
were fixed and stained with DAPI, or prepared for flow cytometry by
trypsinization, washing in PBS, fixation in 90% ethanol for 1 h at 4 C, and
washing again in PBS. DNA was labeled with 50  g ml
 1 propidium io-
dide (Sigma-Aldrich) in PBS containing 25  g ml
 1 RNase A for 30 min at
37 C in the dark. Stained cells were sorted and analyzed in the FACS Core
Facility at the University of Virginia.
In vitro ubiquitination
In vitro ubiquitination reactions were performed as described previously
(Cockman et al., 2000). The energy regenerating system, methylated ubiq-
uitin, and ubiquitin aldehyde were purchased from Boston Biochem, Inc.
p190A mutants, including the isolated GBD (amino acids 1–266), section
1 (amino acids 379–646), section 2 (amino acids 647–918), and section 3
(amino acids 919–1183) of the MD, and the RhoGAP domain (amino acids
1260–1469) were cloned into the pKH3 plasmid (a gift from I. Macara,
University of Virginia), using BamHI and EcoRI restriction digestions. All
constructs including luciferase as a negative control were in vitro–tran-
scribed and –translated from the plasmids in the presence of 20  Ci
[
35S]methionine (1,175 Ci mmol
 1; Amersham Biosciences) using TnT
Quick Coupled Reticulocyte Lysate Transcription/Translation SystemsT
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(Promega). Products of the reaction were analyzed by 7% SDS-PAGE and
autoradiography after treatment of the gels with Amplify reagent (Amer-
sham Biosciences). Densitometric analysis of [
35S]-bands was accom-
plished with ImageQuant, whereas GraphPad Prism was used for statistical
analysis and graphing. For quantitation of the experiments, the area of the
lane above the translated protein containing ubiquitinated p190 was di-
vided by the area above the translated protein alone. The ratio is graphed
as fold ubiquitination.
In vivo ubiquitination
HeLa cells were synchronized in mitosis with lactacystin (a proteasome in-
hibitor; Calbiochem) added at the time of release from nocodazole. Cells
were lysed in RIPA-p-Tyr lysis buffer containing 50 mM NEM (Sigma-
Aldrich) and 10  M lactacystin. 2 mg of clarified extract was immunopre-
cipitated as described previously (Chang et al., 1995a) with a combination
(3  g each) of anti-p190 (Transduction Laboratories) and 3D4 (Chang et
al., 1995b) mAbs. Precipitated proteins were separated on 7% SDS-PAGE
and immunoblotted with rabbit p27 anti-p190 polyclonal antibody (Chang
et al., 1995b) or ubiquitin mAb (Santa Cruz Biotechnology, Inc.) at 1:1,000
and 1:100 dilutions, respectively. Immune complexes were detected with
HRP-conjugated anti–rabbit or anti–mouse IgG (Amersham Biosciences)
and Femto reagent (Pierce Chemical Co.). Images were captured using Al-
phaInnotech software. MDA-MB-468 cells were synchronized and lysed
as above. Anti-p190 (Transduction Laboratories) and 8C10 (Chang et al.,
1995b) mAbs were used for immunoprecipitation, and the anti-p190 mAb
(Transduction Laboratories) was used for Western blotting. Membranes
were incubated with secondary antibody and visualized by ECL.
Degradation assay
HeLa cells were transfected with the indicated 1–3  g HA-tagged p190
plasmids using Polyfect per 100-mm tissue culture dish. 24 h after transfec-
tion, one of two duplicate dishes was incubated with 40 ng/ml nocodazole
for 16 h, washed repeatedly to remove the nocodazole, replenished with
fresh medium, and allowed to progress through mitosis for 40 min at 37 C.
The control dish was maintained as an asynchronously cycling population.
Cells were lysed using RIPA buffer, and 100  g of lysate protein was sepa-
rated by 7% SDS-PAGE and subjected to Western immunoblotting as de-
scribed in the Western blotting section. Densitometric analysis using Al-
phaEase software was performed to obtain the ratios of p190/MAPK
protein, and the values were graphed using GraphPad.
Online supplemental material
Fig. S1 shows the variable amounts of tet-inducible overexpression of HA-
tagged p190 in different clones of MDA-MB-468 breast cancer cells and
the dose and time analysis of this overexpression. Figs. S2 and S3 show
that endogenous p190 localizes to the cleavage furrow with actin and is
degraded during mitosis in HeLa cells, similar to its localization and degra-
dation in 468 cells. Fig. S4 shows the phenotype induced by gene silenc-
ing of p190A in 468 cells. Online supplemental materials are available at
http://www.jcb.org/cgi/content/full/jcb.200308007/DC1.
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